A Phase 1/2 Study of Olaparib in Combination With Radium-223 in Men With Metastatic Castration-Resistant Prostate Cancer With Bone Metastases
Not yet recruiting
Phase of Trial: Phase I/II
Latest Information Update: 24 Apr 2018
At a glance
- Drugs Olaparib (Primary) ; Radium 223 chloride (Primary)
- Indications Adenocarcinoma; Bone metastases; Prostate cancer
- Focus Adverse reactions; Therapeutic Use
- 17 Apr 2018 Planned initiation date changed from 5 Apr 2018 to 5 Oct 2018.
- 28 Feb 2018 Planned initiation date changed from 5 Jan 2018 to 5 Apr 2018.
- 26 Oct 2017 New trial record